Substances, users and markets (2016-2017)
08.02.2018 - Drug use in France: recent trends and emerging phenomena, Tendances No 121.Read more
"25x-NBOMe" type molecules
23.01.2018 - Summary explaining how 25x-NBOMe were able to attract obvious interest.Read more
Captagon: a deconstructed myth
19.12.2017 - Drugs, international challenges No.10 puts the so-called “terrorist drug” to the test.Read more
Latest news from the EMCDDA
Guide on responding to drug problems
24.10.2017 - How to respond to the problems of older heroin users? How to tackle deaths from highly potent fentanils? How to prevent harms from drug and alcohol use in festivals and clubs? These are among the questions explored by a new European guide released by the EMCDDA. Drawing on insights from 30 countries, Health and social responses to drug problems: a European guide presents the agency's first overview of actions and interventions currently available to address the consequences of illicit drug use. It is designed to benefit those approaching drug problems from a public health planning perspective as well as frontline workers and practitioners.
Drug supply monitoring
07.12.2017 - The EMCDDA presents in a new paper its current thinking on the conceptual framework for monitoring drug markets, crime and supply reduction.
Drugs and the darknet
28.11.2017 - The EMCDDA and Europol present the latest understanding of how darknet markets function, the threats they pose to health and security and how Europe can respond.
Drug testing in schools
22.11.2017 - This EMCDDA paper (17 p.) evaluates the effectiveness of random testing in schools, based on studies conducted students aged 13 to 19 years, in the United States.
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2017 EMCDDA European Drug Report.
Country drug reports 2017
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.